CVS Health Q2 rev +10%, EPS $1.48; lowers GAAP EPS guidance to $6.53-$6.75

CVS HEALTH Corp

2023-Q2 EPS reported $3.13 revenue$174,199,000,000

Revenue $88.9B, +10.3% YoY; GAAP diluted EPS $1.48 (down from $2.29); adj EPS $2.21 (down from $2.53).
Full-year GAAP diluted EPS guidance cut to $6.53-$6.75 from $6.90-$7.12; adj EPS guidance confirmed $8.50-$8.70.
Operating income $3.23B, down $1.44B YoY; adjusted operating income $4.48B down $521M.
Completed Oak Street Health acquisition on May 2, 2023; returned $795M to shareholders via dividends in Q2.
Year-to-date cash flow from operations $13.3B; reaffirmed FY cash flow guidance $12.5B-$13.5B.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CVS HEALTH Corp reported the three months ended June 30, 2023 results: revenue $88,921, EPS $1.48. Guidance lowered.

Period: the three months ended June 30, 2023
Revenue: $88,921
EPS: $1.48
Guidance: lowered
Result: reported results

Exact text from the filing

Adjusted EPS of $4.41 • Generated cash flow from operations of $13.3 billion Three Months Ended June 30, In millions, except per share amounts 2023 2022 Change Total revenues $ 88,921 $ 80,636 $ 8,285 Operating income 3,234 4,669 (1,435) Adjusted operating income (1) 4,481 5,002 (521) Diluted earnings per share $ 1.48 $ 2.29 $ (0.81) Adjusted EPS (2) $ 2.21 $

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CVS HEALTH Corp reported 2023 Full-year results: EPS $6.53 to $6.75. Guidance lowered.

Period: 2023 Full-year
EPS: $6.53 to $6.75
Guidance: lowered
Result: guidance update

Exact text from the filing

Revised GAAP diluted EPS guidance range to $6.53 to $6.75 from $6.90 to $7.12

View on SEC.gov

Browse all earnings releases →

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000064803-23-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.